MADRIGAL PHARMACEUTICALS, INC. Insider Trading for July 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MADRIGAL PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MADRIGAL PHARMACEUTICALS, INC. for July 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | CRAVES FRED B | Director | Grant | A | 0.00 | 119,380 | 0 | 119,380 | 0 to 119.4 K |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | CRAVES FRED B | Director | Grant | A | 0.00 | 5,538,474 | 0 | 5,538,474 | 0 to 5.5 M |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | CRAVES FRED B | Director | Grant | A | 0.00 | 296,067 | 0 | 296,067 | 0 to 296.1 K |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | Schneebaum Marc R | Chief Financial Off ... | Option Exercise | A | 9.45 | 91,876 | 868,228 | 91,876 | |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | Schneebaum Marc R | Chief Financial Off ... | Grant | A | 0.00 | 22,969 | 0 | 42,277 | 19.3 K to 42.3 K (+118.96 %) |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | A | 9.45 | 287,115 | 2,713,237 | 287,115 | |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | FRIEDMAN PAUL A | Chief Executive Off ... | Grant | A | 0.00 | 729,066 | 0 | 729,066 | 0 to 729.1 K |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | FRIEDMAN PAUL A | Chief Executive Off ... | Grant | A | 0.00 | 143,557 | 0 | 143,703 | 146 to 143.7 K (+98,326.71 %) |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | FRIEDMAN PAUL A | Chief Executive Off ... | Grant | A | 0.00 | 146 | 0 | 146 | 0 to 146 |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | Taub Rebecca | Chief Medical Offic ... | Option Exercise | A | 9.45 | 143,557 | 1,356,614 | 143,557 | |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | Taub Rebecca | Chief Medical Offic ... | Grant | A | 0.00 | 28,740 | 0 | 432,872 | 404.1 K to 432.9 K (+7.11 %) |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | Taub Rebecca | Chief Medical Offic ... | Grant | A | 0.00 | 404,132 | 0 | 404,132 | 0 to 404.1 K |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | Taub Rebecca | Chief Medical Offic ... | Grant | A | 0.00 | 729,066 | 0 | 729,066 | 0 to 729.1 K |
| Jul 22 2016 | SNTA | SYNTA PHARMACEUTIC ... | Schor Chen | Former President an ... | Payment of Exercise | F | 9.48 | 14,250 | 135,090 | 37,178 | 51.4 K to 37.2 K (-27.71 %) |
| Jul 22 2016 | SNTA | SYNTA PHARMACEUTIC ... | Schor Chen | Former President an ... | Grant | A | 0.00 | 42,857 | 0 | 51,428 | 8.6 K to 51.4 K (+500.02 %) |
| Jul 22 2016 | SNTA | SYNTA PHARMACEUTIC ... | Schneebaum Marc R | SVP and CFO | Payment of Exercise | F | 9.48 | 8,548 | 81,035 | 19,308 | 27.9 K to 19.3 K (-30.69 %) |
| Jul 22 2016 | SNTA | SYNTA PHARMACEUTIC ... | Schneebaum Marc R | SVP and CFO | Grant | A | 0.00 | 25,714 | 0 | 27,856 | 2.1 K to 27.9 K (+1,200.47 %) |
| Jul 22 2016 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | Former SVP, Gen. Co ... | Payment of Exercise | F | 9.48 | 8,550 | 81,054 | 17,730 | 26.3 K to 17.7 K (-32.53 %) |
| Jul 22 2016 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | Former SVP, Gen. Co ... | Grant | A | 0.00 | 25,714 | 0 | 26,280 | 566 to 26.3 K (+4,543.11 %) |